Newly discovered brain response to obesity drug may inform future treatments

The FDA-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. However, where and how the drug acts in the brain was not fully understood, until now. A new preclinical study shows how liraglutide crosses the brain’s blood barrier to engage with a region of the brainstem known as the nucleus tractus solitarius, which is responsible for balancing food intake and energy expenditure.

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *